Thyroid hormone level is associated with the frequency and severity of Guillain-Barre syndrome

被引:8
作者
Huang, Yuanyuan [1 ]
Ying, Zhaojian [2 ]
Chen, Zhibo [1 ]
Xiang, Weiwei [1 ]
Su, Zhongqian [1 ]
Quan, Weiwei [1 ]
Weng, Yiyun [1 ]
Zhang, Xu [1 ]
机构
[1] Wenzhou Med Univ, Dept Neurol, Affiliated Hosp 1, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Dept Resp & Crit Care Med, Affiliated Hosp 1, Wenzhou, Peoples R China
关键词
Guillain-Barre syndrome; TSH; FT4; FT4/FT3; oxidative stress; MULTIPLE-SCLEROSIS; LIPID-PEROXIDATION; OXIDATIVE STRESS; REMYELINATION; DEMYELINATION; DISEASE; SYSTEM; OXYGEN; SERUM;
D O I
10.1080/00207454.2016.1278541
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: Guillain-Barre syndrome (GBS) is a neurodegenerative and inflammatory demyelination disorder, and oxidative stress is concerned with the pathogenesis of the disease. Also, we found that thyroid hormone level is correlated to the oxidative and antioxidant status in previous studies. Our study was aimed to find the possible relationship between the frequency and severity of GBS and thyroid hormone levels. Materials andmethods: We measured serum levels of thyroid-stimulating hormone (TSH), free thyroxine (FT4) and free triiodothyronine (FT3) in 238 individuals, including 90 GBS, 44 multiple sclerosis and 104 healthy controls. Results: Our findings demonstrate that the patients with GBS had lower TSH and higher FT4, FT4/FT3 than healthy controls in the normal range. Furthermore, it was also shown in our study that TSH levels in patients with GBS were correlated with disease severity measured by the Hughes Functional Grading Scale. Conclusion: Lower TSH, higher FT4 and FT4/FT3 stand for the oxidative status and are associated with the incidence and severity of GBS.
引用
收藏
页码:893 / 899
页数:7
相关论文
共 26 条
  • [1] Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: II-The developmental pattern of neurons in relation to oxidative stress and antioxidant defense system
    Ahmed, O. M.
    Ahmed, R. G.
    El-Gareib, A. W.
    El-Bakry, A. M.
    El-Tawab, S. M. Abd
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2012, 30 (06) : 517 - 537
  • [2] Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: I. The development of the thyroid hormones-neurotransmitters and adenosinergic system interactions
    Ahmed, O. M.
    El-Tawab, S. M. Abd
    Ahmed, R. G.
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2010, 28 (06) : 437 - 454
  • [3] A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration
    Ausó, E
    Lavado-Autric, R
    Cuevas, E
    del Rey, FE
    de Escobar, GM
    Berbel, P
    [J]. ENDOCRINOLOGY, 2004, 145 (09) : 4037 - 4047
  • [4] Gender differences in thyroid system function: relevance to bipolar disorder and its treatment
    Bauer, Michael
    Glenn, Tasha
    Pilhatsch, Maximilian
    Pfennig, Andrea
    Whybrow, Peter C.
    [J]. BIPOLAR DISORDERS, 2014, 16 (01) : 58 - 71
  • [5] Chachamovitz DSD, 2016, ENDOCR J, V63, P495, DOI 10.1507/endocrj.EJ15-0458
  • [6] Serum and Cerebrospinal Fluid Antioxidant Activity and Lipid Peroxidation in Guillain-Barre Syndrome and Multiple Sclerosis Patients
    Ghabaee, Mojdeh
    Jabedari, Behnam
    Al-E-Eshagh, Naser
    Ghaffarpour, Majid
    Asadi, Farzad
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2010, 120 (04) : 301 - 304
  • [7] CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY
    HUGHES, RAC
    NEWSOMDAVIS, JM
    PERKIN, GD
    PIERCE, JM
    [J]. LANCET, 1978, 2 (8093) : 750 - 753
  • [8] Jiang Y, 2009, NEUROENDOCRINOL LETT, V30, P85
  • [9] Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease
    Johansson, Per
    Almqvist, Erik G.
    Johansson, Jan-Ove
    Mattsson, Niklas
    Hansson, Oskar
    Wallin, Anders
    Blennow, Kaj
    Zetterberg, Henrik
    Svensson, Johan
    [J]. PSYCHONEUROENDOCRINOLOGY, 2013, 38 (07) : 1058 - 1066
  • [10] 3,3′,5-triiodothyroxine inhibits apoptosis and oxidative stress by the PKM2/PKM1 ratio during oxygen-glucose deprivation/reperfusion AC16 and HCM-a cells T3 inhibits apoptosis and oxidative stress by PKM2/PKM1 ratio
    Li, Qi
    Qi, Xin
    Jia, Wenjun
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 475 (01) : 51 - 56